Im steve clemons, editor at large of the hill thank you for joining us for covid19 and a responsible rx supply chain, looking at the resiliency of the Prescription Drug supply chain during a global pandemic. Id like to thank the distribution alliance. The coronavirus pandemic has upended our lives and forced the new normal upon us. While accommodations can be made for our lifestyle choices theres little legibility when it comes to our health care. For those most at riskexaccess to regular medication isnt a choice and in some cases its a matter of life and death. Both the Healthcare System and patience have changed their behaviors. As a consequence concerns have arisen regarding drug availability and shortages. What are stakeholders doing o to ensure that disruptions do not occur and there is collaboration between the public and private sectors and what plans are being put in place for distribution of this vaccine once it becomes available . We discuss all of this with some of the smart
He received his undergraduate and masters degrees in history. I got to know david when he was running on Hillary Clintons campaign. He is a distinguished fellow, National Security and board of law school. Scholar of the university of texas. He spent many hours together in the situation room and previously served president home and security and counterterrorism. Middle Eastern Affairs and counterterrorism, john received several awards for his contributions including National Security panel, Public Service medal and fbi director medallion. Please join me in welcoming david and john. David, congratulations on the release of the book before we get to the specific aspects, can you give an over view of what the book is about . Why you wanted to write about this topic. I want to say thank you for being here and i am excited to talk about these issues. I would say i wrote this book because after 2016 after russia attacked our democracy, i found bizarre, dangerous the operation was treated as u
Drug that meant people werent dying of this. In the study, only two people died no placebo up against the remdesivir they were using these are early results but promising signs of hope. The dow futures indicated up by about 700 points if we continue like this, that would put the dow in positive t territory. S p indicated up about 75 points and the nasdaq indicated up by about 177. Lets look at the treasury market yesterday, those yields for the 10year were under a little pressure they had come back down even more we were talking about under 0. 7 looking now at the 10year treasury, you will see on this friday, last trading day of the week, the 10year is yielding 0. 64 . Looking at oil and the shut down of Oil Production and cuts of the number of barrels being produced a day around the globe, you did see prices come back down it is not enough to keep up with the dropping demand. Watching that too. This morning, wti is down to 18. 61 a barrel well be talking markets, potential medical bre
Thank you for and drop inviting us to this conversation. Weve been around for about 19 months. We have three areas of focus. First of all we run the only full topic fund focus specifically on jewish people of color. We are interested in funding Leadership Development grassroots building and knowledge making. Developing kind of new ideas and concepts in organizations. Leadership organizations for the Jewish Community. Advocating for those of color. The second thing we had the privilege of doing is conducting research for the entire National Jewish community system. So in the last 18 months we conducted a study called consistencies with stanford university. Is a demographic analysis of the United States. And the third thing we do is education the community. Is such a privilege. We get to work with fellowships and Leadership Teams and boards. With influencers in the ecosystem and theres an idea of helping to understand theres a Multiracial Community becoming even more multiracial. So we n
Work of our National Innovation initiative. Now, another 17 years later, here we are again, once again finding ourselves at the precipice of transformational change. Today well hear stories about these changes as theyre foundational to our Flagship National commission on innovation and competitiveness frontiers. The commission cochaired by the Council Board on this stage is a multiyear effort to reimagine americas innovation potential and to chart a new path for competitiveness in the 21st century. And as this slide shows, just a little less than a year ago, with our core leadership team, we began to build this effort. And by august we had pulled together a powerful and diverse set of commissioners, nearly 60 leaders from across this country from industry, from academia, from our Labor Union Community and our National Labs. And the commission has already started their work. As deborah mentioned, todays launch is our 2020 roadmap of activities that we hope will change the future traject